Treatment of atopic dermatitis with dupilumab in Taiwan: dynamic changes of IgE levels as a potential response biomarker

被引：0
|
作者：
Tzu Hung Huang
Yin-Chun Chen
Sheng-Yiao Lin
Szu-Hao Chiu
Ting-Ting Yang
Li-Wen Chiu
Yang-Yi Chen
Cheng-Che E. Lan
机构：
[1] Kaohsiung Medical University Hospital,Department of Dermatology
[2] Kaohsiung Medical University,Graduate Institute of Clinical Medicine, College of Medicine
[3] Kaohsiung Medical University,Department of Dermatology, College of Medicine
来源：
European Journal of Dermatology | 2019年 / 29卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：658 / 659
页数：1
相关论文
共 50 条
  • [21] Thrombocytopenia After Dupilumab for the Treatment of Atopic Dermatitis
    Bressan, Aline Lopes
    Troncoso, Natalia Torres
    Sousa, Nathalie Andrade
    DERMATITIS, 2025, 36 (01) : e88 - e89
  • [22] Dupilumab in the Treatment of Cheilitis in Atopic Dermatitis Patients
    Shan, Jinpeng
    Ali, Kamran
    Da, Jiayang
    Li, Menghua
    Qiu, Yunmi
    Lou, HaiYue
    Wu, Liming
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2022, 15 : 2437 - 2443
  • [23] Serum dupilumab levels after 16 weeks of treatment are not associated with treatment response or side effects in atopic dermatitis patients
    Spekhorst, L.
    de Graaf, M.
    Loeff, F.
    Zuithoff, N.
    Bakker, D.
    Boesjes, C.
    Thijs, J.
    Achten, R.
    van Wijk, F.
    Rispens, T.
    de Bruin-Weller, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (12) : S201 - S201
  • [24] Recognition of atopic keratoconjunctivitis during treatment with dupilumab for atopic dermatitis
    Cheng, Justine
    Jiang, Lai
    Morrow, Nicole C.
    Avdic, Armin
    Fairley, Janet A.
    Ling, Jennifer J.
    Greiner, Mark A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (01) : 265 - 267
  • [25] Psoriasiform Dermatitis After Initiation of Treatment with Dupilumab for Atopic Dermatitis
    Fowler, Emilie
    Silverberg, Jonathan I.
    Fox, Joshua D.
    Yosipovitch, Gil
    DERMATITIS, 2019, 30 (03) : 234 - 236
  • [26] Dupilumab therapy reduces urinary biopyrrin levels in atopic patients: a new possible biomarker of oxidative status in atopic dermatitis
    Raimondo, Annunziata
    Balestrino, Alessia
    Ligrone, Luigi
    Lembo, Serena
    ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2024, 159 (01) : 50 - 54
  • [27] Dupilumab: an evidence-based review of its potential in the treatment of atopic dermatitis
    Eshtiaghi, Panteha
    Gooderham, Melinda J.
    CORE EVIDENCE, 2018, 13 : 13 - 20
  • [28] Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy
    D'Erme, Angelo Massimiliano
    Romanelli, Marco
    Chiricozzi, Andrea
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 1473 - 1480
  • [29] Dupilumab in Dermatology: Potential for Uses Beyond Atopic Dermatitis
    Maloney, Nolan J.
    Tegtmeyer, Kyle
    Zhao, Jeffrey
    Worswick, Scott
    JOURNAL OF DRUGS IN DERMATOLOGY, 2019, 18 (10) : 1053 - 1057
  • [30] Dupilumab with concomitant Janus kinase inhibitor: a novel treatment strategy for atopic dermatitis with poor response to dupilumab
    Yang, Nali
    Chen, Lele
    Shao, Junyi
    Jiang, Fan
    Liu, Jingjing
    Li, Zhiming
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (05) : 828 - 830
12345